Tóth, L.; Juhász, M.F.; Szabó, L.; Abada, A.; Kiss, F.; Hegyi, P.; Farkas, N.; Nagy, G.; Helyes, Z.
Janus Kinase Inhibitors Improve Disease Activity and Patient-Reported Outcomes in Rheumatoid Arthritis: A Systematic Review and Meta-Analysis of 24,135 Patients. Int. J. Mol. Sci. 2022, 23, 1246.
https://doi.org/10.3390/ijms23031246
AMA Style
Tóth L, Juhász MF, Szabó L, Abada A, Kiss F, Hegyi P, Farkas N, Nagy G, Helyes Z.
Janus Kinase Inhibitors Improve Disease Activity and Patient-Reported Outcomes in Rheumatoid Arthritis: A Systematic Review and Meta-Analysis of 24,135 Patients. International Journal of Molecular Sciences. 2022; 23(3):1246.
https://doi.org/10.3390/ijms23031246
Chicago/Turabian Style
Tóth, Lilla, Márk F. Juhász, László Szabó, Alan Abada, Fruzsina Kiss, Péter Hegyi, Nelli Farkas, György Nagy, and Zsuzsanna Helyes.
2022. "Janus Kinase Inhibitors Improve Disease Activity and Patient-Reported Outcomes in Rheumatoid Arthritis: A Systematic Review and Meta-Analysis of 24,135 Patients" International Journal of Molecular Sciences 23, no. 3: 1246.
https://doi.org/10.3390/ijms23031246
APA Style
Tóth, L., Juhász, M. F., Szabó, L., Abada, A., Kiss, F., Hegyi, P., Farkas, N., Nagy, G., & Helyes, Z.
(2022). Janus Kinase Inhibitors Improve Disease Activity and Patient-Reported Outcomes in Rheumatoid Arthritis: A Systematic Review and Meta-Analysis of 24,135 Patients. International Journal of Molecular Sciences, 23(3), 1246.
https://doi.org/10.3390/ijms23031246